Statements
17. CAPITAL COMMITMENTS
Company No. 691431 - D
Company No. 691431 - D
14. HIRE-PURCHASE PAYABLES
Hire-purchase payables consist of the following:
Total outstanding obligations 83,799 214,133
Less: Interest in suspense (10,228) (28,515)
Principal outstanding 73,571 185,618
Less: Amount due for settlement within 12 months
(shown under current liabilities) (43,488) (112,047)
Non-current portion 30,083 73,571
The non-current portion is repayable as follows:
Financial years ending 31 December:
2011 - 43,488
2012 19,000 19,000
2013 11,083 11,083
30,083 73,571
15. OTHER PAYABLES AND ACCRUALS
Developmental grants
awarded payables 66,099,850 73,601,772 66,099,850 73,601,772
Other payables 6,389,247 5,883,986 6,389,247 5,883,986
Accruals 564,879 532,551 558,879 530,551
73,053,976 80,018,309 73,047,976 80,016,309 The developmental grants awarded payables cover for periods up to 2 years.
Group and Company
2010 2009
RM RM
Group and Company
2010 2009
RM RM
Group Company
2010 2009 2010 2009
RM RM RM RM
16. LEASE COMMITMENTS
Total future minimum lease payments under non-cancellable operating leases are as follows:
17. CAPITAL COMMITMENTS
The Company leases a number of computer equipment under operating leases. The leases run for a period of three years. None of the leases include contingent rentals.
The capital commitments of the Group and of the Company will be recognised in the financial statements when the goods or works are delivered or completed in accordance to the contract it relates to.
Less than one year 178,300 185,473
Between one and five years 49,045 398,509
227,345 583,982 Group and Company
2010 2009
RM RM
Approved and contracted for:
Property, plant and
equipment 3,500,460 897,745 3,500,460 897,745
Patent and licenses 9,900,677 27,061,104 9,900,677 27,061,104
Freehold land 33,539,000 69,063,508 - -
Construction of building 49,550,000 - - -
96,490,137 97,022,357
11,143,834
13,401,137 27,958,849 Approved but not contracted for:
Property, plant and
equipment 11,143,834 - , -
Freehold land 8,494,200 - - -
Construction of building 74,100,000 - - -
93,738,034 - 11,143,834 -
190,228,171 97,022,357 24,544,971 27,958,849
Group Company
2010 2009 2010 2009
RM RM RM RM
Company No. 691431 - D
MALAYSIAN BIOTECHNOLOGY CORPORATION SDN. BHD.
(Incorporated in Malaysia)
DECLARATION BY THE OFFICER PRIMARILY RESPONSIBLE FOR THE FINANCIAL MANAGEMENT OF THE COMPANY
I, SYED AGIL BIN SYED HASHIM, the Officer primarily responsible for the financial management of MALAYSIAN BIOTECHNOLOGY CORPORATION SDN. BHD., do solemnly and sincerely declare that the financial statements of the Group and of the Company, which comprise the balance sheets as of 31 December 2010, and the income statements, statements of changes in equity and cash flow statements for the year then ended, and a summary of significant accounting policies and other explanatory information, as set out on pages 118 to 143 are, in my opinion, correct and I make this solemn declaration conscientiously believing the same to be true and by virtue of the provisions of the Statutory Declarations Act, 1960.
SYED AGIL BIN SYED HASHIM
Subscribed and solemnly declared by the abovenamed SYED AGIL BIN SYED HASHIM at KUALA LUMPUR this 28th day of April 2011.
Before me,
COMMISSIONER FOR OATHS Company No. 691431 - D
MALAYSIAN BIOTECHNOLOGY CORPORATION SDN. BHD.
(Incorporated in Malaysia) STATEMENT BY DIRECTORS
The directors of MALAYSIAN BIOTECHNOLOGY CORPORATION SDN. BHD. state that, in their opinion, the financial statements of the Group and of the Company, which comprise the balance sheets as of 31 December 2010, and the income statements, statements of changes in equity and cash flow statements for the year then ended, and a summary of significant accounting policies and other explanatory information, as set out on pages 118 to 143, are drawn up in accordance with Private Entity Reporting Standards and the provisions of the Companies Act, 1965 in Malaysia so as to give a true and fair view of financial position of the Group and of the Company as of 31 December 2010 and of the financial performance and the cash flows of the Group and of the Company for the year ended on that date.
Signed on behalf of the Board of Directors in accordance with a resolution of the Directors,
TAN SRI DATUK DR AHMAD ZAHARUDIN BIN IDRUS
DATO’ ISKANDAR MIZAL BIN MAHMOOD 28 April 2011
Company No. 691431 - D
MALAYSIAN BIOTECHNOLOGY CORPORATION SDN. BHD.
(Incorporated in Malaysia)
DECLARATION BY THE OFFICER PRIMARILY RESPONSIBLE FOR THE FINANCIAL MANAGEMENT OF THE COMPANY
I, SYED AGIL BIN SYED HASHIM, the Officer primarily responsible for the financial management of MALAYSIAN BIOTECHNOLOGY CORPORATION SDN. BHD., do solemnly and sincerely declare that the financial statements of the Group and of the Company, which comprise the balance sheets as of 31 December 2010, and the income statements, statements of changes in equity and cash flow statements for the year then ended, and a summary of significant accounting policies and other explanatory information, as set out on pages 118 to 143 are, in my opinion, correct and I make this solemn declaration conscientiously believing the same to be true and by virtue of the provisions of the Statutory Declarations Act, 1960.
SYED AGIL BIN SYED HASHIM
Subscribed and solemnly declared by the abovenamed SYED AGIL BIN SYED HASHIM at KUALA LUMPUR this 28th day of April 2011.
Before me,
COMMISSIONER FOR OATHS Company No. 691431 - D
MALAYSIAN BIOTECHNOLOGY CORPORATION SDN. BHD.
(Incorporated in Malaysia) STATEMENT BY DIRECTORS
The directors of MALAYSIAN BIOTECHNOLOGY CORPORATION SDN. BHD. state that, in their opinion, the financial statements of the Group and of the Company, which comprise the balance sheets as of 31 December 2010, and the income statements, statements of changes in equity and cash flow statements for the year then ended, and a summary of significant accounting policies and other explanatory information, as set out on pages 118 to 143, are drawn up in accordance with Private Entity Reporting Standards and the provisions of the Companies Act, 1965 in Malaysia so as to give a true and fair view of financial position of the Group and of the Company as of 31 December 2010 and of the financial performance and the cash flows of the Group and of the Company for the year ended on that date.
Signed on behalf of the Board of Directors in accordance with a resolution of the Directors,
TAN SRI DATUK DR AHMAD ZAHARUDIN BIN IDRUS
DATO’ ISKANDAR MIZAL BIN MAHMOOD 28 April 2011
Yap Sook Yee Manager, Secretarial
Anuar Haniff Senior Manager, Developmental Program
Not in the picture: Adrian Abdul Ghani - Vice President, Regulatory Affairs Haslina Hamidan - Manager, Branding Shahreel Riza Idris - Manager, Financial Transaction Aida Shafinaz Allias - Vice President, Industrial
Nora Mohamed - Vice President, Evaluation Faizah Pakhrurazi - Knowledge Management Jay Padasian
Vice President, Healthcare
Marlia Othman Executive, Business Unit Support
Anita Daud Charles
Head, Corporate Communications Bio-XCell
Elina Jani Executive, Business Development Kanimoli Ramaiah
Vice President, Talent Management Nurul Aida Basri
Manager, Shared Facilities Mohd Faisal Abu Hassan
Assistant, Business Unit Support Tengku Nila Putri Tengku Ilham
Vice President, Capability Development
Rajini Kanth
Manager, Business Unit Support
Sharifah Hanifah Syed Abd Aziz Senior Vice President, Legal & Secretarial
Ahmad Izral Abd Karim Senior Manager, Finance & Accounting
Dr. Kodi Isparan Kandasamy Vice President, Agriculture